Furthermore, liver fat is also positively correlated to plasma FGF21 (168, 169) and plasma FGF21 is increased in patients with NAFLD (170–173) and NASH (158, 174–176). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.